Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.

Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1434-40. doi: 10.1016/j.ijrobp.2008.03.020. Epub 2008 May 28.

2.

Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.

Frasier LL, Holden S, Holden T, Schumacher JR, Leverson G, Anderson B, Greenberg CC, Neuman HB.

JAMA Oncol. 2016 Jan;2(1):95-101. doi: 10.1001/jamaoncol.2015.3717. Erratum in: JAMA Oncol. 2016 Jan;2(1):146.

3.

Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.

Huo D, Hou N, Jaskowiak N, Winchester DJ, Winchester DP, Yao K.

Ann Surg Oncol. 2015 Dec;22(13):4295-304. doi: 10.1245/s10434-015-4528-x. Epub 2015 Mar 28.

PMID:
25820998
4.

One decade later: trends and disparities in the application of post-mastectomy radiotherapy since the release of the American Society of Clinical Oncology clinical practice guidelines.

Dragun AE, Huang B, Gupta S, Crew JB, Tucker TC.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e591-6. doi: 10.1016/j.ijrobp.2012.02.002.

PMID:
22768990
5.

Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.

Shirvani SM, Pan IW, Buchholz TA, Shih YC, Hoffman KE, Giordano SH, Smith BD.

Cancer. 2011 Oct 15;117(20):4595-605. doi: 10.1002/cncr.26081. Epub 2011 Jun 27.

6.

Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.

Le Scodan R, Selz J, Stevens D, Bollet MA, de la Lande B, Daveau C, Lerebours F, Labib A, Bruant S.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e1-7. doi: 10.1016/j.ijrobp.2010.12.054. Epub 2011 Mar 4.

PMID:
21377284
7.

The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).

Shim SJ, Park W, Huh SJ, Choi DH, Shin KH, Lee NK, Suh CO, Keum KC, Kim YB, Ahn SD, Kim SS, Ha SW, Chie EK, Kim K, Shin HS, Kim JH, Lee HS.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):65-72. doi: 10.1016/j.ijrobp.2013.09.021. Epub 2013 Oct 22.

PMID:
24161425
8.

Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process.

Jagsi R, Abrahamse P, Morrow M, Griggs JJ, Schwartz K, Katz SJ.

Cancer. 2009 Mar 15;115(6):1185-93. doi: 10.1002/cncr.24164.

9.

Postmastectomy radiation for N2/N3 breast cancer: factors associated with low compliance rate.

Chu QD, Caldito G, Miller JK, Townsend B.

J Am Coll Surg. 2015 Apr;220(4):659-69. doi: 10.1016/j.jamcollsurg.2014.12.045. Epub 2015 Jan 14.

PMID:
25797752
10.

Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.

Truong PT, Olivotto IA, Whelan TJ, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

CMAJ. 2004 Apr 13;170(8):1263-73.

11.

A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.

Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):797-804.

PMID:
14967436
12.

Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.

McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, Hortobagyi GN, Hunt KK, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):392-8. doi: 10.1016/j.ijrobp.2014.02.013. Epub 2014 Apr 7.

PMID:
24721590
13.

The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.

Cassidy RJ, Liu Y, Kahn ST, Jegadeesh NK, Liu X, Subhedar PD, Arciero CA, Gillespie TW, Torres MA.

Cancer. 2017 Aug 1;123(15):2829-2839. doi: 10.1002/cncr.30675. Epub 2017 Apr 7.

PMID:
28387923
14.

Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.

PMID:
15817335
15.

Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.

Tendulkar RD, Rehman S, Shukla ME, Reddy CA, Moore H, Budd GT, Dietz J, Crowe JP, Macklis R.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e577-81. doi: 10.1016/j.ijrobp.2012.01.076. Epub 2012 May 5.

PMID:
22560546
16.

Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.

Nagar H, Mittendorf EA, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward WA, Gonzalez-Angulo AM, Hunt KK, Buchholz TA, Yu TK.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):782-7. doi: 10.1016/j.ijrobp.2010.06.027. Epub 2011 Aug 30.

PMID:
21885207
17.

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1-3 positive lymph nodes: a retrospective study.

Chitapanarux I, Tharavichitkul E, Jakrabhandu S, Klunklin P, Onchan W, Srikawin J, Pukanhaphan N, Traisathit P, Vongtama R.

J Radiat Res. 2014 Jan 1;55(1):121-8. doi: 10.1093/jrr/rrt084. Epub 2013 Jun 20.

18.

Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers.

Francis SR, Frandsen J, Kokeny KE, Gaffney DK, Poppe MM.

Breast. 2017 Apr;32:156-161. doi: 10.1016/j.breast.2017.02.001. Epub 2017 Feb 10.

PMID:
28193571
19.

Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information.

Punglia RS, Weeks JC, Neville BA, Earle CC.

J Clin Oncol. 2006 Jul 20;24(21):3474-82.

PMID:
16849764
20.

Supplemental Content

Support Center